Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00793481 · ClinicalTrials.gov registry record

Vascular Reactivity in Metabolic Syndrome and Diabetic Patients Using Diffuse Optical Spectroscopy

A clinical trial, sponsored by University of California, Irvine.

Completed
Registry status
50
Enrollment target

NCT00793481: Completed study, sponsored by University of California, Irvine.

NCT00793481 is a clinical trial that has completed, run by University of California, Irvine. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00793481 has completed, sponsored by University of California, Irvine.

COMPLETED
Registry status
50 participants
Enrollment target

Study Summary

Metabolic Syndrome is a highly prevalent condition that is comprised of several major clustering factors that increase the risk for developing cardiovascular disease. Diffuse Optical Spectroscopy is a non-invasively measure can show changes in the microvasculature of human. Diffuse Optical Spectroscopy measures the optical absorption and scattering properties of near-infrared light in tissues such as muscle in order to quantify the absolute concentration of oxygenated and deoxygenated hemoglobin, water, and lipids. It provides quantitative and functional information on the microvasculature related to tissue perfusion, metabolic changes, and indicators of tissue damage.

Primary Outcome

Diffuse Optical Spectroscopy non-invasively measure changes in the microvasculature

Interventions

  • DEVICE Diffuse Optical Spectroscopy

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2008-11
Est. Completion 2013-11
University of California, Irvine

368 total trials

What the finished NCT00793481 record still lists

NCT00793481 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which Diffuse Optical Spectroscopy is the first listed.

NCT00793481 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00793481 about?

NCT00793481 is a clinical study titled "Vascular Reactivity in Metabolic Syndrome and Diabetic Patients Using Diffuse Optical Spectroscopy". Metabolic Syndrome is a highly prevalent condition that is comprised of several major clustering factors that increase the risk for developing cardiovascular disease. Diffuse Optical Spectroscopy is a non-invasively measure can show changes in the microvasculature of human. Diffuse Optical Spectrosc...

What is the current status of trial NCT00793481?

This trial is currently completed. The enrollment target is 50 participants. The study started on 2008-11. Estimated completion is 2013-11.

What interventions are being tested in trial NCT00793481?

The interventions under investigation include: Diffuse Optical Spectroscopy (DEVICE).

Who is sponsoring clinical trial NCT00793481?

This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00793481, the US trial registry maintained by the National Library of Medicine. NCT00793481 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.